{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T04:16:51Z","timestamp":1773807411628,"version":"3.50.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,31]],"date-time":"2020-01-31T00:00:00Z","timestamp":1580428800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,1,31]],"date-time":"2020-01-31T00:00:00Z","timestamp":1580428800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81673657"],"award-info":[{"award-number":["81673657"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Med Ther"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>As a compound Chinese medicine, Zhenqing Recipe (ZQR) has been shown to ameliorate hyperglycemia, hyperlipidemia, fatty liver and insulin resistance in patients with diabetes and diabetic rats. In this paper, we further examined the effect of ZQR on diabetes complicated by non-alcoholic fatty liver disease (NAFLD) and the underlying molecular mechanisms.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Diabetic rats with NAFLD were developed by a high-fat diet (HFD) with low-dose streptozotocin (STZ) injection for 4\u2009weeks. These rats were randomly separated into the diabetic model (DM), ZQR, metformin (Met), adenovirus expressing-salt-induced kinase 1 (Ad-SIK1) and adenovirus labeled with green fluorescent protein (Ad-GFP) groups. The effects on hepatic expression of gluconeogenic genes, glycolipid metabolism and pathological changes were subsequently detected.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Serum glucose, triglycerides (TG), total cholesterol (TC) and hepatic TG were reduced in the ZQR group. The histopathological and immunohistochemical changes in the liver and pancreas in the ZQR group were significantly alleviated. The decrease of SIK1 expression was observed in the liver of diabetic rats induced by HFD and STZ. SIK1 overexpression in the liver relieved hyperglycemia, hyperlipidemia and fatty liver. Both the mRNA and protein levels of CREB-regulated transcription co-activator 2 (CRTC2), phosphoenolpyruvate carboxykinase (PEPCK) and glucose-6-phosphatase (G6Pase) in the liver were drastically reduced, whereas those of SIK1 were markedly increased in the ZQR group compared to levels in the DM group. Compared with the DM group, Ser577 phosphorylation of SIK1 was obviously reduced in the liver, while T182 phosphorylation of SIK1 and S171 phosphorylation of CRTC2 were evidently increased in the Ad-SIK1, Met and ZQR groups.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>ZQR ameliorates hepatic gluconeogenesis and lipid storage in diabetic rats induced by HFD and STZ by activating the SIK1\/CRTC2 signaling pathway. Upregulating hepatic SIK1 by ZQR may represent an efficient strategy for treating diabetes with NAFLD.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12906-019-2811-2","type":"journal-article","created":{"date-parts":[[2020,1,31]],"date-time":"2020-01-31T16:03:51Z","timestamp":1580486631000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Zhenqing recipe attenuates non-alcoholic fatty liver disease by regulating the SIK1\/CRTC2 signaling in experimental diabetic rats"],"prefix":"10.1186","volume":"20","author":[{"given":"Daofei","family":"Song","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiuying","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,1,31]]},"reference":[{"key":"2811_CR1","doi-asserted-by":"crossref","unstructured":"American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2014;37(Suppl 1):S81\u201390.","DOI":"10.2337\/dc14-S081"},{"issue":"1","key":"2811_CR2","doi-asserted-by":"publisher","first-page":"e000011","DOI":"10.1136\/bmjdrc-2013-000011","volume":"2","author":"NA Bello","year":"2014","unstructured":"Bello NA, Pfeffer MA, Skali H, McGill JB, Rossert J, Olson KA, Weinrauch L, Cooper ME, de Zeeuw D, Rossing P, et al. Retinopathy and clinical outcomes in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia. BMJ Open Diabetes Res Care. 2014;2(1):e000011.","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"3","key":"2811_CR3","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1097\/MOG.0b013e3283294a18","volume":"25","author":"O Cheung","year":"2009","unstructured":"Cheung O, Sanyal AJ. Recent advances in nonalcoholic fatty liver disease. Curr Opin Gastroenterol. 2009;25(3):230\u20137.","journal-title":"Curr Opin Gastroenterol"},{"issue":"31","key":"2811_CR4","doi-asserted-by":"publisher","first-page":"7006","DOI":"10.3748\/wjg.v22.i31.7006","volume":"22","author":"L Abenavoli","year":"2016","unstructured":"Abenavoli L, Milic N, Di Renzo L, Preveden T, Medic-Stojanoska M, De Lorenzo A. Metabolic aspects of adult patients with nonalcoholic fatty liver disease. World J Gastroenterol. 2016;22(31):7006\u201316.","journal-title":"World J Gastroenterol"},{"issue":"11","key":"2811_CR5","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/nrgastro.2013.171","volume":"10","author":"R Loomba","year":"2013","unstructured":"Loomba R, Sanyal AJ. The global NAFLD epidemic. Nat Rev Gastroenterol Hepatol. 2013;10(11):686\u201390.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"16","key":"2811_CR6","doi-asserted-by":"publisher","first-page":"10446","DOI":"10.1074\/jbc.M900096200","volume":"284","author":"YS Yoon","year":"2009","unstructured":"Yoon YS, Seo WY, Lee MW, Kim ST, Koo SH. Salt-inducible kinase regulates hepatic lipogenesis by controlling SREBP-1c phosphorylation. J Biol Chem. 2009;284(16):10446\u201352.","journal-title":"J Biol Chem"},{"key":"2811_CR7","volume-title":"Metabolic regulation by salt inducible kinases","author":"R Berdeaux","year":"2011","unstructured":"Berdeaux R. Metabolic regulation by salt inducible kinases, vol. 6; 2011."},{"issue":"44","key":"2811_CR8","doi-asserted-by":"publisher","first-page":"42334","DOI":"10.1074\/jbc.M204602200","volume":"277","author":"H Takemori","year":"2002","unstructured":"Takemori H, Katoh Y, Horike N, Doi J, Okamoto M. ACTH-induced nucleocytoplasmic translocation of salt-inducible kinase. Implication in the protein kinase A-activated gene transcription in mouse adrenocortical tumor cells. J Biol Chem. 2002;277(44):42334\u201343.","journal-title":"J Biol Chem"},{"issue":"1","key":"2811_CR9","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.cmet.2004.12.003","volume":"1","author":"BB Kahn","year":"2005","unstructured":"Kahn BB, Alquier T, Carling D, Hardie DG. AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. Cell Metab. 2005;1(1):15\u201325.","journal-title":"Cell Metab"},{"issue":"3","key":"2811_CR10","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1152\/physrev.00011.2008","volume":"89","author":"GR Steinberg","year":"2009","unstructured":"Steinberg GR, Kemp BE. AMPK in health and disease. Physiol Rev. 2009;89(3):1025\u201378.","journal-title":"Physiol Rev"},{"issue":"1","key":"2811_CR11","first-page":"73","volume":"29","author":"HY Quan","year":"2012","unstructured":"Quan HY, Yuan HD, Jung MS, Ko SK, Park YG, Chung SH. Ginsenoside re lowers blood glucose and lipid levels via activation of AMP-activated protein kinase in HepG2 cells and high-fat diet fed mice. Int J Mol Med. 2012;29(1):73\u201380.","journal-title":"Int J Mol Med"},{"issue":"12","key":"2811_CR12","doi-asserted-by":"publisher","first-page":"2730","DOI":"10.1111\/j.1742-4658.2006.05291.x","volume":"273","author":"Y Katoh","year":"2006","unstructured":"Katoh Y, Takemori H, Lin XZ, Tamura M, Muraoka M, Satoh T, Tsuchiya Y, Min L, Doi J, Miyauchi A, et al. Silencing the constitutive active transcription factor CREB by the LKB1-SIK signaling cascade. FEBS J. 2006;273(12):2730\u201348.","journal-title":"FEBS J"},{"issue":"5","key":"2811_CR13","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1002\/jcb.21737","volume":"104","author":"YK Hashimoto","year":"2008","unstructured":"Hashimoto YK, Satoh T, Okamoto M, Takemori H. Importance of autophosphorylation at Ser186 in the A-loop of salt inducible kinase 1 for its sustained kinase activity. J Cell Biochem. 2008;104(5):1724\u201339.","journal-title":"J Cell Biochem"},{"issue":"1","key":"2811_CR14","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3892\/ijmm.2013.1377","volume":"32","author":"J Yu","year":"2013","unstructured":"Yu J, Hu X, Yang Z, Takemori H, Li Y, Zheng H, Hong S, Liao Q, Wen X. Salt-inducible kinase 1 is involved in high glucose-induced mesangial cell proliferation mediated by the ALK5 signaling pathway. Int J Mol Med. 2013;32(1):151\u20137.","journal-title":"Int J Mol Med"},{"issue":"1","key":"2811_CR15","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.cmet.2011.06.003","volume":"14","author":"HV Lin","year":"2011","unstructured":"Lin HV, Accili D. Hormonal regulation of hepatic glucose production in health and disease. Cell Metab. 2011;14(1):9\u201319.","journal-title":"Cell Metab"},{"issue":"4","key":"2811_CR16","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1002\/dmrr.217","volume":"17","author":"J Radziuk","year":"2001","unstructured":"Radziuk J, Pye S. Hepatic glucose uptake, gluconeogenesis and the regulation of glycogen synthesis. Diabetes Metab Res Rev. 2001;17(4):250\u201372.","journal-title":"Diabetes Metab Res Rev"},{"issue":"6852","key":"2811_CR17","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/35093050","volume":"413","author":"JC Yoon","year":"2001","unstructured":"Yoon JC, Puigserver P, Chen G, Donovan J, Wu Z, Rhee J, Adelmant G, Stafford J, Kahn CR, Granner DK, et al. Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature. 2001;413(6852):131\u20138.","journal-title":"Nature"},{"issue":"6852","key":"2811_CR18","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/35093131","volume":"413","author":"S Herzig","year":"2001","unstructured":"Herzig S, Long F, Jhala US, Hedrick S, Quinn R, Bauer A, Rudolph D, Schutz G, Yoon C, Puigserver P, et al. CREB regulates hepatic gluconeogenesis through the coactivator PGC-1. Nature. 2001;413(6852):179\u201383.","journal-title":"Nature"},{"issue":"1","key":"2811_CR19","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.cell.2004.09.013","volume":"119","author":"J Lin","year":"2004","unstructured":"Lin J, Wu PH, Tarr PT, Lindenberg KS, St-Pierre J, Zhang CY, Mootha VK, Jager S, Vianna CR, Reznick RM, et al. Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1alpha null mice. Cell. 2004;119(1):121\u201335.","journal-title":"Cell"},{"issue":"5","key":"2811_CR20","doi-asserted-by":"publisher","first-page":"E1137","DOI":"10.1152\/ajpendo.00158.2009","volume":"297","author":"M Saberi","year":"2009","unstructured":"Saberi M, Bjelica D, Schenk S, Imamura T, Bandyopadhyay G, Li P, Jadhar V, Vargeese C, Wang W, Bowman K, et al. Novel liver-specific TORC2 siRNA corrects hyperglycemia in rodent models of type 2 diabetes. Am J Phys Endocrinol Metab. 2009;297(5):E1137\u201346.","journal-title":"Am J Phys Endocrinol Metab"},{"issue":"7","key":"2811_CR21","doi-asserted-by":"publisher","first-page":"3087","DOI":"10.1073\/pnas.0914897107","volume":"107","author":"Y Wang","year":"2010","unstructured":"Wang Y, Inoue H, Ravnskjaer K, Viste K, Miller N, Liu Y, Hedrick S, Vera L, Montminy M. Targeted disruption of the CREB coactivator Crtc2 increases insulin sensitivity. Proc Natl Acad Sci U S A. 2010;107(7):3087\u201392.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7062","key":"2811_CR22","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1038\/nature03967","volume":"437","author":"SH Koo","year":"2005","unstructured":"Koo SH, Flechner L, Qi L, Zhang X, Screaton RA, Jeffries S, Hedrick S, Xu W, Boussouar F, Brindle P, et al. The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism. Nature. 2005;437(7062):1109\u201311.","journal-title":"Nature"},{"issue":"1","key":"2811_CR23","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1136\/gutjnl-2016-312431","volume":"66","author":"Y Rotman","year":"2017","unstructured":"Rotman Y, Sanyal AJ. Current and upcoming pharmacotherapy for non-alcoholic fatty liver disease. Gut. 2017;66(1):180\u201390.","journal-title":"Gut"},{"issue":"8","key":"2811_CR24","first-page":"782","volume":"25","author":"XY Wen","year":"2006","unstructured":"Wen XY, Liang X, Liu H, Wang QH. Effects of Zhenqing prescription in the treatment of 50 senile patients with diabetic nephropathy. Herald of Medicine. 2006;25(8):782\u20134.","journal-title":"Herald of Medicine"},{"issue":"1","key":"2811_CR25","first-page":"47","volume":"03","author":"XY Wen","year":"2011","unstructured":"Wen XY, Wen-Guang XU, Ling X, Ming-Wang XU, Hao L, Hong Z, Luo Q, Qiu-Hong N. Anti-diabetic activity of Zhenqing recipe and Ligustri Lucidi Fructus in type 2 diabetic rats. Chinese Herbal Medicines. 2011;03(1):47\u201353.","journal-title":"Chinese Herbal Medicines"},{"issue":"1","key":"2811_CR26","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.jep.2012.04.028","volume":"142","author":"X Wen","year":"2012","unstructured":"Wen X, Zeng Y, Liu L, Zhang H, Xu W, Li N, Jia X. Zhenqing recipe alleviates diabetic nephropathy in experimental type 2 diabetic rats through suppression of SREBP-1c. J Ethnopharmacol. 2012;142(1):144\u201350.","journal-title":"J Ethnopharmacol"},{"issue":"4","key":"2811_CR27","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1142\/S0192415X12500541","volume":"40","author":"W Huang","year":"2012","unstructured":"Huang W, Yu J, Jia X, Xiong L, Li N, Wen X. Zhenqing recipe improves glucose metabolism and insulin sensitivity by repressing hepatic FOXO1 in type 2 diabetic rats. Am J Chin Med. 2012;40(4):721\u201333.","journal-title":"Am J Chin Med"},{"issue":"7","key":"2811_CR28","first-page":"846","volume":"34","author":"H Zheng","year":"2014","unstructured":"Zheng H, Hong SC, Yu J, Wen XY. Effect of zhenqing recipe on non-alcoholic fatty liver in type 2 diabetes rats and the expression of SIK1. Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine. 2014;34(7):846\u201352.","journal-title":"Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine"},{"issue":"6","key":"2811_CR29","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1097\/PAI.0b013e3181a13bf2","volume":"17","author":"CJ Wang","year":"2009","unstructured":"Wang CJ, Zhou ZG, Holmqvist A, Zhang H, Li Y, Adell G, Sun XF. Survivin expression quantified by image pro-plus compared with visual assessment. Appl Immunohistochemistry & molecular morphology : AIMM. 2009;17(6):530\u20135.","journal-title":"Appl Immunohistochemistry & molecular morphology : AIMM"},{"key":"2811_CR30","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.lfs.2017.02.001","volume":"173","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Takemori H, Wang C, Fu J, Xu M, Xiong L, Li N, Wen X. Role of salt inducible kinase 1 in high glucose-induced lipid accumulation in HepG2 cells and metformin intervention. Life Sci. 2017;173:107\u201315.","journal-title":"Life Sci"},{"key":"2811_CR31","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.biopha.2016.10.061","volume":"84","author":"MT Jalali","year":"2016","unstructured":"Jalali MT, Mohammadtaghvaei N, Larky DA. Investigating the effects of Capparis spinosa on hepatic gluconeogenesis and lipid content in streptozotocin-induced diabetic rats. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2016;84:1243\u20138.","journal-title":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie"},{"issue":"1","key":"2811_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jep.2003.12.031","volume":"92","author":"WL Li","year":"2004","unstructured":"Li WL, Zheng HC, Bukuru J, De Kimpe N. Natural medicines used in the traditional Chinese medical system for therapy of diabetes mellitus. J Ethnopharmacol. 2004;92(1):1\u201321.","journal-title":"J Ethnopharmacol"},{"issue":"8","key":"2811_CR33","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s11655-011-0810-3","volume":"17","author":"PK Prabhakar","year":"2011","unstructured":"Prabhakar PK, Doble M. Mechanism of action of natural products used in the treatment of diabetes mellitus. Chin J Integrative Med. 2011;17(8):563\u201374.","journal-title":"Chin J Integrative Med"},{"issue":"3","key":"2811_CR34","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.jep.2005.10.031","volume":"105","author":"CS Kumari","year":"2006","unstructured":"Kumari CS, Govindasamy S, Sukumar E. Lipid lowering activity of Eclipta prostrata in experimental hyperlipidemia. J Ethnopharmacol. 2006;105(3):332\u20135.","journal-title":"J Ethnopharmacol"},{"issue":"3","key":"2811_CR35","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/j.jep.2011.07.033","volume":"137","author":"K He","year":"2011","unstructured":"He K, Li X, Chen X, Ye X, Huang J, Jin Y, Li P, Deng Y, Jin Q, Shi Q, et al. Evaluation of antidiabetic potential of selected traditional Chinese medicines in STZ-induced diabetic mice. J Ethnopharmacol. 2011;137(3):1135\u201342.","journal-title":"J Ethnopharmacol"},{"issue":"1\u20133","key":"2811_CR36","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.ejphar.2009.11.019","volume":"628","author":"ZH Wang","year":"2010","unstructured":"Wang ZH, Hsu CC, Huang CN, Yin MC. Anti-glycative effects of oleanolic acid and ursolic acid in kidney of diabetic mice. Eur J Pharmacol. 2010;628(1\u20133):255\u201360.","journal-title":"Eur J Pharmacol"},{"issue":"5","key":"2811_CR37","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1002\/jemt.20039","volume":"63","author":"MD Mythili","year":"2004","unstructured":"Mythili MD, Vyas R, Akila G, Gunasekaran S. Effect of streptozotocin on the ultrastructure of rat pancreatic islets. Microsc Res Tech. 2004;63(5):274\u201381.","journal-title":"Microsc Res Tech"},{"issue":"4","key":"2811_CR38","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.phrs.2005.05.004","volume":"52","author":"K Srinivasan","year":"2005","unstructured":"Srinivasan K, Viswanad B, Asrat L, Kaul CL, Ramarao P. Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening. Pharmacol Res. 2005;52(4):313\u201320.","journal-title":"Pharmacol Res"},{"issue":"4","key":"2811_CR39","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1038\/sj.emboj.7600110","volume":"23","author":"JM Lizcano","year":"2004","unstructured":"Lizcano JM, Goransson O, Toth R, Deak M, Morrice NA, Boudeau J, Hawley SA, Udd L, Makela TP, Hardie DG, et al. LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK\/PAR-1. EMBO J. 2004;23(4):833\u201343.","journal-title":"EMBO J"},{"issue":"43","key":"2811_CR40","doi-asserted-by":"publisher","first-page":"25997","DOI":"10.1074\/jbc.M115.679266","volume":"290","author":"MF Hogan","year":"2015","unstructured":"Hogan MF, Ravnskjaer K, Matsumura S, Huising MO, Hull RL, Kahn SE, Montminy M. Hepatic insulin resistance following chronic activation of the CREB Coactivator CRTC2. J Biol Chem. 2015;290(43):25997\u20136006.","journal-title":"J Biol Chem"},{"issue":"1","key":"2811_CR41","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s12944-016-0316-2","volume":"15","author":"J Woo","year":"2016","unstructured":"Woo J, Kang S. Diet change and exercise enhance protein expression of CREB, CRTC 2 and lipolitic enzymes in adipocytes of obese mice. Lipids Health Dis. 2016;15(1):147.","journal-title":"Lipids Health Dis"},{"key":"2811_CR42","first-page":"91","volume":"29","author":"N Rakieten","year":"1963","unstructured":"Rakieten N, Rakieten ML, Nadkarni MV. Studies on the diabetogenic action of streptozotocin (NSC-37917). Cancer Chemother Rep. 1963;29:91\u20138.","journal-title":"Cancer Chemother Rep"},{"issue":"5","key":"2811_CR43","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.biocel.2003.10.002","volume":"36","author":"PJ Klover","year":"2004","unstructured":"Klover PJ, Mooney RA. Hepatocytes: critical for glucose homeostasis. Int J Biochem Cell Biol. 2004;36(5):753\u20138.","journal-title":"Int J Biochem Cell Biol"}],"container-title":["BMC Complementary Medicine and Therapies"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-019-2811-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12906-019-2811-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-019-2811-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,30]],"date-time":"2021-01-30T00:10:03Z","timestamp":1611965403000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccomplementalternmed.biomedcentral.com\/articles\/10.1186\/s12906-019-2811-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,31]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["2811"],"URL":"https:\/\/doi.org\/10.1186\/s12906-019-2811-2","relation":{},"ISSN":["2662-7671"],"issn-type":[{"value":"2662-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,31]]},"assertion":[{"value":"9 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The protocol for using animals in the present study was approved by the research Ethics Committee of Tongji Medical College, Huazhong University of Science and Technology (Ethical approval no: 822).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"27"}}